PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17683829-6	2007	We further tested whether the intraperitoneal injection of IL-1beta, known to aggravate the ibotenate-induced lesions, could modify the expression pattern of VIP-related genes.	Ibotenic Acid	92-101	vasoactive intestinal peptide	Homo sapiens	158-161	
17683829-7	2007	Finally, we concluded using histological analysis that VIP[ala(11,22,28)], a synthetic VPAC(1) agonist completely reversed the aggravating effects of IL-1beta on ibotenate-induced lesions of the periventricular white matter.	Ibotenic Acid	162-171	vasoactive intestinal peptide	Homo sapiens	55-58	
17683829-9	2007	All together, our results suggest that an activation of VIP/VPAC(1) signaling cascade in the vicinity of the injury site could circumvent the synergizing degenerative effects of ibotenate and pro-inflammatory cytokines.	Ibotenic Acid	178-187	vasoactive intestinal peptide	Homo sapiens	56-59